Albany NY, United States: Echinocandin is a new class of antifugal agents that work by inhibiting cell wall synthesis.
Albany NY, United States: Echinocandin is a new class of antifugal agents that work by inhibiting cell wall synthesis. These agents act by inhibiting β-1, 3-glucan synthase complex. Caspofungin is the first approved echinocandin candidate. Caspofungin was approved by the U.S. FDA for the treatment of invasive candidiasis in patients resistant to other antifungal agents, empirical therapy in febrile neutropenia, esophageal candidiasis, and certain forms of candidemia. Echinocandins offer several advantages over other antifungal agents. The potential benefits of echinocandins include less risk of drug–drug interactions, novel mechanism of action, and lower incidence of adverse effects.
Read Report Overview – https://www.transparencymarketresearch.com/echinocandins-market.html
Global Echinocandins Market: Key Trends
The global echinocandins market is projected to grow at a rapid pace during the forecast period. Echinocandins have been studied extensively and offer advantages such as broad spectrum of activity including strains of fungi resistant to other antifungal agents and fewer side effects with no hepatotoxicity and nephrotoxicity compared to macrolide and azole antifungals. The expanding indications of echinocandins in secondary fungal infections have shown promising results which is expected to drive the global echinocandins market.
Global Echinocandins Market: Segmentation
The global echinocandins market can be segmented based on drug type, indication, and region. In terms of drug type, the market can be classified into caspofungin, micafungin, and anidulafungin. Based on indication, the global echinocandins market can be categorized into esophageal candidiasis, candidemia with invasive candidiasis, febrile neutropenia, invasive aspergillosis, and others. In terms of region, the global echinocandins market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=64898
Candidemia is a major cause of mortality in immunosuppressed patients due to rise in invasive fungal infections. These patients show reduced susceptibility to azole antifungals. Fluconazole has been the mainstay of the treatment of candedimia patients; however, it is losing ground due to increase in resistance among Candida species. Moreover, aspergillosis is a major contributor of morbidity in patients with hematological malignancies and those undergoing transplants. Amphotericin B used against invasive fungal infections leads to nephrotoxicity and high incidence of infusion related adverse effects. Introduction of echinocandins against this backdrop is a promising development in antifungal armamentarium.
Global Echinocandins Market: Regional Analysis
North America is projected to account for the largest share of the global market in terms of revenue during the forecast period. High research and development activities in the field of antifungal drugs, ongoing clinical trials with echinocandins, and increase in incidence of fungal infections in the region are the major factors attributed to the high market share of the region. According to the U.S. Department of Health & Human Services, invasive candidiasis is one of the common health care-associated infection. Around 46,000 cases of invasive candidiasis are reported in the U.S. each year.
Get COVID-19 Analysis on Echinocandins Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=64898
Europe is anticipated to account for the second largest share of the global market owing to high awareness among people about the treatment options and rise in prevalence of chronic diseases. Asia Pacific is expected to witness strong growth during the forecast period. Rise in government initiatives to improve health care, increase in geriatric population, surge in disposable income, and high investment by key players in the emerging markets in Asia Pacific are likely to fuel the growth of the echinocandins market in the region.
Global Echinocandins Market: Competitive Landscape
The global echinocandins market is highly fragmented due to presence of large number of global as well as new players. Major players operating in the market are Alkem Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Merck & Co., Inc., Fresenius SE & Co. KGaA, Xellia Pharmaceuticals, and MSD Pharmaceuticals Pvt. Ltd.
This upcoming business intelligence report is intended to be a one-stop market research solution to guide organizations in taking timely and effective decisions for their business growth. The ongoing study is the culmination of our deep expertise on data science methods, combined with an unparalleled understanding of the external environment and analysis of the industries.
Make an Enquiry before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=64898
Each of the reports by TMR aims at offering a detailed scrutiny of the value chain of our current and prospective customers, takes them from identifying value propositions, and subsequently assist their business executives to implement right strategies to create customer value. We believe that creating and sustaining the customer value is the key pivot on which business executives can create profits for their organizations and increase the market shares, continuously and with sustainability.
Each of our touchpoints through which we engage with the organization/enterprise during the primary research enables us to understand the internal environment it operates in and the ways in which the external environment influences its growth.
Browse more Reports by Transparency Market Research:
Health Care Information Systems Market: The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times. Continued increase in the cost of health care over the last few years has forced health care institutions to adopt health care IT systems in order to cut costs.
Prefilled Syringes Market: Prefilled syringes have the fundamental medications filled in the specific sum that are anything but difficult to utilize. Patients can utilize prefilled syringes all alone or can take help from a relative for parenteral controlling of the medication. Prefilled syringes are helpful, clean, precise, and moderate, which make them appropriate to be used by patients. Such advantages are boosting the growth of the global prefilled syringes market.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/